Search research articles
Contact Us
Filters
Showing results (111-120 of 122) with videos related to
Page
of 13
Sort By:
BMC Cancer
|
May 21, 2020
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
Robert Wesolowski, Andrew Stiff, Dionisia Quiroga, et al.
The Lancet Regional Health. Southeast Asia
|
February 20, 2026
Burden of subclinical coronary atherosclerosis among asymptomatic adults: the REACH-Rural India Study
Avinash Kumar Raghupathy, Mohanraj Sundaresan, Pudhiavan Arun, et al.
Stroke
|
November 6, 2019
Influence of Guidelines in Endovascular Therapy Decision Making in Acute Ischemic Stroke: Insights From UNMASK EVT
Nima Kashani, Johanna M Ospel, Bijoy K Menon, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
|
June 19, 2023
Worry and Mindfulness Differentially Impact Symptom Burden Following Treatment Among Breast Cancer Survivors: Findings From a Randomized Crossover Trial
Megan E Renna, Annelise A Madison, Juan Peng, et al.
European Journal of Breast Health
|
October 15, 2021
Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience
Hannah Rinehardt, Mahmoud Kassem, Evan Morgan, et al.
International Journal of Behavioral Medicine
|
July 13, 2022
Distress Disorder Histories Relate to Greater Physical Symptoms Among Breast Cancer Patients and Survivors: Findings Across the Cancer Trajectory
Megan E Renna, M Rosie Shrout, Annelise A Madison, et al.
Therapeutic Advances in Medical Oncology
|
December 28, 2023
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer
Nicole O Williams, Dionisia Quiroga, Courtney Johnson, et al.
JAMA Oncology
|
February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial
Otto Metzger Filho, Daniel G Stover, Sarah Asad, et al.
Stroke
|
July 23, 2019
Factors Associated With the Decision-Making on Endovascular Thrombectomy for the Management of Acute Ischemic Stroke
Gustavo Saposnik, Bijoy K Menon, Nima Kashani, et al.
NPJ Breast Cancer
|
November 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness
Otto Metzger-Filho, Katharine Collier, Sarah Asad, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 122) with videos related to
Sort By:
Page
of 13
BMC Cancer
|
May 21, 2020
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
Robert Wesolowski, Andrew Stiff, Dionisia Quiroga, et al.
The Lancet Regional Health. Southeast Asia
|
February 20, 2026
Burden of subclinical coronary atherosclerosis among asymptomatic adults: the REACH-Rural India Study
Avinash Kumar Raghupathy, Mohanraj Sundaresan, Pudhiavan Arun, et al.
Stroke
|
November 6, 2019
Influence of Guidelines in Endovascular Therapy Decision Making in Acute Ischemic Stroke: Insights From UNMASK EVT
Nima Kashani, Johanna M Ospel, Bijoy K Menon, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
|
June 19, 2023
Worry and Mindfulness Differentially Impact Symptom Burden Following Treatment Among Breast Cancer Survivors: Findings From a Randomized Crossover Trial
Megan E Renna, Annelise A Madison, Juan Peng, et al.
European Journal of Breast Health
|
October 15, 2021
Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience
Hannah Rinehardt, Mahmoud Kassem, Evan Morgan, et al.
International Journal of Behavioral Medicine
|
July 13, 2022
Distress Disorder Histories Relate to Greater Physical Symptoms Among Breast Cancer Patients and Survivors: Findings Across the Cancer Trajectory
Megan E Renna, M Rosie Shrout, Annelise A Madison, et al.
Therapeutic Advances in Medical Oncology
|
December 28, 2023
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer
Nicole O Williams, Dionisia Quiroga, Courtney Johnson, et al.
JAMA Oncology
|
February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial
Otto Metzger Filho, Daniel G Stover, Sarah Asad, et al.
Stroke
|
July 23, 2019
Factors Associated With the Decision-Making on Endovascular Thrombectomy for the Management of Acute Ischemic Stroke
Gustavo Saposnik, Bijoy K Menon, Nima Kashani, et al.
NPJ Breast Cancer
|
November 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness
Otto Metzger-Filho, Katharine Collier, Sarah Asad, et al.
Page
of 13